{"name":"Radio Isotope Therapy of America","slug":"radio-isotope-therapy-of-america","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Indium-111 pentetreotide","genericName":"Indium-111 pentetreotide","slug":"indium-111-pentetreotide","indication":"Diagnostic imaging of neuroendocrine tumors (carcinoid tumors, gastroenteropancreatic neuroendocrine tumors)","status":"marketed"}]}],"pipeline":[{"name":"Indium-111 pentetreotide","genericName":"Indium-111 pentetreotide","slug":"indium-111-pentetreotide","phase":"marketed","mechanism":"Indium-111 pentetreotide is a radiolabeled somatostatin analog that binds to somatostatin receptors on neuroendocrine tumor cells, allowing for diagnostic imaging and localization of these tumors.","indications":["Diagnostic imaging of neuroendocrine tumors (carcinoid tumors, gastroenteropancreatic neuroendocrine tumors)","Localization of somatostatin receptor-positive tumors"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPNktoTUF2TW9HcHlQZHU3WEZpZEp5YmF5cVdHRXNuUFA0WE9CTWkzU3d0c216empKY2kwb2p0RnA1bXpNanNoSEszMFl3dElLeGdQX2ZVNFloTEluSTVBNFA2TU5ITlZkSlVBMUhVMmUxLUxUZnBVd2dHdVk4VTMwMmNVVm53eGEtQ3ozb09rQlgyamlteEVyT2U4ZkhGMWRyUWlBUURCQU5KcjdHQUtpdkQtZmhNX1JtMHc?oc=5","date":"2026-02-25","type":"pipeline","source":"Fierce Pharma","summary":"With Texas site, Novartis rounds out radiopharma production plans amid $23B US investment blitz - Fierce Pharma","headline":"With Texas site, Novartis rounds out radiopharma production plans amid $23B US investment blitz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxONDF5d0ZuVVUxSTNuR0Frd3IxREl5ZTRpWlF5RlRrV3JFOFFZUnJQSWtCSGk3LWhjTGFLRVEwaUtBNVhmcHlzZFVJTGVYWk42cXlsMkM0bTRHdEVEYkE0RWVvU3UyVWRnWlRPVm53N3M4eDF2MWVxODc2U0tKMGxLR1BtYWNqVHlfQ01Gbmo1M1NqMjJteDFtZW45dzFMemdtcWwyT056Y0g4MGNBY3pZSGJVX1hIa1NZRzNMM3pvZ0ZPZEQ1R0R4LW41Q1NmanBlR3hiN3ZxUGd4cnBMTHhrREt2OHN1MWd0?oc=5","date":"2026-02-17","type":"pipeline","source":"GlobeNewswire","summary":"Why the Radiopharmaceutical CDMO Market is a Smart Investment: USD 8.50 Bn by 2035 - GlobeNewswire","headline":"Why the Radiopharmaceutical CDMO Market is a Smart Investment: USD 8.50 Bn by 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQbEpTRDRBOGNicFRjWkpSSjk4QnhjSGxPa2Y5MzBiYmRWSUVYSnY0czR4OHlVbTY5MmJfenRzVTVUcTM1dzFtR19JejViczB0RWNsX013OWxvZXdGMFFobHpmem9fd2hoOGtCd3BEd25YY3pFSDZfZG5TZlpUZFYwb3ZkMTBrSzVEcGJmNzd6OU53NDRqRnlwM05Wd1BlbEo0VmZyamVhTlN6Y0tDWWhR?oc=5","date":"2026-01-09","type":"pipeline","source":"Fierce Pharma","summary":"Novartis charts next US investment with plan for new radiopharma plant in Florida - Fierce Pharma","headline":"Novartis charts next US investment with plan for new radiopharma plant in Florida","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNRHE3bWtWSmVZazB6MFZzTFRzb1hWRFN4T1VvMXJtdXgtOEU0Tk94OHlDZkdXMkFuWDZadkYtR041c1g3dTVhTzd4YXJMYnU1cDNJYU5SSzZnRnNXd2xMcTdwRm5yNFZTc1Y0aVNSR2I2b3RQX0pKUkpGWWFQZHRsdHF4d2FvX2FsbWVsQ25RMFEtODFKU1BidHFkcEc5WFBPcTVlMXdBclFSYmlTdHREcVJDN0hHNWFkQS1BRldQMnJQUXV6dUgtbXZ1Wl9XRVEzSlZaOHlIN1k3TExvTzBmT3Q2NU81RjM0dmR4Zl9jbU5OdmNpUVFJNHg0Ykk0WGlBZ05tWEJRQkJtbUE?oc=5","date":"2026-01-09","type":"pipeline","source":"Novartis","summary":"Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment - Novartis","headline":"Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPcm85aWxDbkItTmdadFl0ZDdNc05zdEdwUUVhTlE3NS1UY0hnV19DdEtkNlJzcTlMMFNxb1BMRm9HVDNOZW9aNkdha2QyTWxtUExndEoxY05NWERIZzFsYnB2RmFiZlpaYjR1RklmYklZTVFfalJuN1p0X2E0VUhERXRKa1pTbW1uaVE?oc=5","date":"2025-11-27","type":"pipeline","source":"ThinkChina","summary":"Where China stands in the nuclear medicine gold rush - ThinkChina","headline":"Where China stands in the nuclear medicine gold rush","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxONjF3Y2ZlVGtyaTViMEZXUnZFenM3MmNVem9KTXQ2Z1gySzdRa3VzVS1HbHc4MDZ0emtOWWxUYnNVMmQ2ZDVnUXVXMUdLVVBLOGdUNzhmM05EQXZfODI3dFJpaGx1ajdmU2VOQ1JxUV9kRWd1alJtQzUyNV9fWDl1UTRRd3Z3WEk1RUc5bnRSMTNnYjhIWXpLVTV6S3VvRlRucXY1UVJWcUQ3UzRWRnJHY3AwUGVuRUd1UmdudjVPWUtfSzBYWlQ2aDFmTQ?oc=5","date":"2025-11-12","type":"pipeline","source":"Pharmaceutical Commerce","summary":"Novartis Expands US Footprint With New Radioligand Therapy Manufacturing Facility in California - Pharmaceutical Commerce","headline":"Novartis Expands US Footprint With New Radioligand Therapy Manufacturing Facility in California","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOTzdCQ254SVJEMzJGejk5YjBkd2hPOGRRcUFNcUlGdzFxcWYzV2NxSXFVYTVRckdGREQ0d1hBUnJ5LVpYOW9ta0RYNFE5dmdpU2VjaWhzRWtxU3lIQmlNdHJJbHZ0RWpJQWpqdlI1X29uN2FibEhEY0dfTUc2RERnRmVRbXpOY2VIdThRaENwdEFUWXU4OGJiVlREZTBTbnBsZmJNWU9IcE5ISXpzNElv?oc=5","date":"2025-10-02","type":"pipeline","source":"Science | AAAS","summary":"New radioactive isotope therapies promise more targeted attacks on cancer - Science | AAAS","headline":"New radioactive isotope therapies promise more targeted attacks on cancer - Science | AAAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNWGQ0MWxuNnJoNkd1VEFnYjg2RHFHZVlTajgyVTJiY3VyQUNGeUlEbm9kQk5DVnlDaW5DWnpqaUZpWWs1NzRLb3RNV2t6MUF6RTJSckRjejI2V24tajNjX3RCZ2lHMnVUQTRPQkZzME1kN095c0RDck82YVNxalFZelZXWTJNWUdFNHFmNGgxcFV4Y2NTUzBfNDZoMUVHNHVpaXRhQnRJM0V4cU1FVWpiRDdlNjBsbGZld25hWDNUNWN2Zw?oc=5","date":"2025-07-10","type":"pipeline","source":"Fierce Biotech","summary":"Radiopharma biotech raises $99M series B to test copper-based diagnostic, therapeutic combo - Fierce Biotech","headline":"Radiopharma biotech raises $99M series B to test copper-based diagnostic, therapeutic combo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQNDlhRWdrdi1ZQUVONERNemRhZER2S1RHTGRhMlNYbnMwYmFzLXZ3Um1YMnlBOU8xUnNNTG9MamcxWTBGc1FnWHRPWkRjYTV2T2lZVHJmSUxHUnIwYzFyVzY0TGVhSVlCYlllbkgtWTVGblMza0ZSS2FyMFV0dEJBR09yUG95NEdGdnlSVUpuNUJjZENNc1JQMWlLMTZRUVBsQmxGdGNvbw?oc=5","date":"2025-06-23","type":"pipeline","source":"BioSpace","summary":"Radiopharmaceuticals Market Size Worth USD 14.44 Billion by 2034 - BioSpace","headline":"Radiopharmaceuticals Market Size Worth USD 14.44 Billion by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNR0twSHktVk9leUVGV0wyVHBycDh6VjFabXRJQnhQSkNzamJOWjBoSFVmSHltYUpTcXV0dXJ6TEhtVFNhdlNIMGwwYlBmbFFtT1FBX1lkV1VuTWVqQ3ZXMjZKaXJ3V1Y0TXdwMk5kWU0ya0Z3RlNPTUN2MVN4akVSRVgyTFBPdERVN0tBc3B3Wk52MEx1aGZvTU9tVVNOanBwZUtjNDFmVXJ4OG1uT1R4bnd3djFERXB2WVdZ?oc=5","date":"2025-05-26","type":"pipeline","source":"Forbes Australia","summary":"Australian startups take on big pharma with precision cancer breakthroughs - Forbes Australia","headline":"Australian startups take on big pharma with precision cancer breakthroughs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQR2pmLWY2dnhVMGVCLWtHTDJYOFZtRlJ0aFBvbVlFbjZIVUhEU0ppRVhEbWxoU2lpM2VSTDZUZUZ5SE5vWUF6WmpWejhrQ0phWEVyTm53aUl1b2RDaGJkS1M3NVBDeUFVTjVtcGR1YS1kRnhIdjZ6ZFFRQzNpODVNWjk5Q1NZV3ZXY2hWUmR3dlZmTlFIOTZLaHlQMVJycGtLX1FJckp3cTY4dw?oc=5","date":"2025-05-09","type":"pipeline","source":"The Pharma Letter","summary":"M&A activity – Radiopharmaceutical therapies are a hot target for investment - The Pharma Letter","headline":"M&A activity – Radiopharmaceutical therapies are a hot target for investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxNZXNiZnloaHIyZ0JrR1UyelcyT25ZVjdYVmgyN3Vzam5hTVotUk5OcURmNHlGN2l6ZHNQTGg3bDRqMmxQcFZxb240YWdzTTdYZUc1N2tXRmRLZVl1VVYzNkprUHZCT0lrQ25WbldVOUxwYktFVUJGVHh4NUVkM19QY0tSSDRBTUtCRkF0WFJITUMzQTRhM3JNakt5Y01lbmFJcENDTU9iMzNoMW5sN0VmLWJhOWMyMlFiTm15VTd3MVdrcGE3QzExWG42TkZUZ2syN3FtY2xQSGJMN0FSS01wYWJ6OTRYS0pKbjFqanNyRmY4aXB2cTJqV0gyMzMteDZNQmc5Vm8xTDhpWWhrbEdVVU91UGJ6MXJtOC0zdFlSODNEV0FxWTFV?oc=5","date":"2025-03-24","type":"pipeline","source":"prnewswire.com","summary":"Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities - prnewswire.com","headline":"Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensi","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}